Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia

Obstetrics and Gynecology

Volumn 88, Issue 3, 1996, Pages 420-427

  Kupferminc, Michael J ^a   Peaceman, Alan M ^a   Aderka, Dan ^a   Wallach, David ^a   Socol, Michael L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CELL SURFACE RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; PREECLAMPSIA; PRIORITY JOURNAL; TARGET CELL;

EID: 0029811939     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00179-2     Document Type: Article

References (28)

1. Clark DA, Lea RG, Podor T, Daya S, Banwatt D, Harley C. Cytokines determining the success or failure of pregnancy. Ann N Y Acad Sci 1991;626:524-36.
2. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991;139:327-35.
3. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992;166:1576-87.
4. Hunt JS. Cytokine networks in the uteroplacental unit: Macrophages as pivotal regulatory cells. J Reprod Immunol 1989;16:1-17.
5. Hunt JS, Soares MJ, Lei MG, Smith RN, Wheaton D, Atherton RA, et al. Products of lipopolysaccharide-activated macrophages (tumor necrosis factor-α, transforming growth factor-β) but not lipopolysaccharide modify DNA synthesis by rat trophoblast cells exhibiting the 80-kDa lipopolysaccharide-binding protein. J Immunol 1989;143:1606-13.
6. Silen ML, Firpo A, Morgello S, Lowry SF, Francus T. Interleukin-1α and tumor necrosis factor-α cause placental injury in the rat. Am J Pathol 1989;135:239-44.
7. Heyborne KD, Witkin SS, McGregor JA. Tumor necrosis factor-α in mid-trimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol 1992;167:920-5.
8. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752-9.
9. Engelmann H, Novick D, Wallach D. Two tumor necrosis factor-binding proteins purified from human urine: Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 1990;265:1531-6.
10. Aderka D, Engelmann H, Wallach D. Soluble tumor necrosis factor receptors in health and disease. In: Fiers W, Buurman WA, eds. Tumor necrosis factor: Molecular and cellular biology and clinical relevance. Basel, Germany: Karger, 1993:191-8.
11. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989;264:11974-80.
12. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
13. Aderka D, Le JM, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989;143:3517-23.
14. Silver RM, Schwinzer B, McGregor JA. Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: Preeclampsia, small-for-gestational-age fetus, and premature labor. Am J Obstet Gynecol 1993;169:1101-5.
15. Kauma SW, Wang Y, Walsh SW. Preeclampsia is associated with decreased placental interleukin-6 production. J Soc Gynecol Invest 1995;2:614-7.
16. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
17. Stark JM. Preeclampsia and cytokine induced oxidative stress. Br J Obstet Gynaecol 1993;100:105-9.
18. Austgulen R, Liabakk NB, Lien E, Espevik T. Increased levels of soluble TNF-α receptors in serum from pregnant women and in serum and urine samples from newborns. Pediatr Res 1993;33: 82-7.
19. Austgulen R, Liabakk NB, Brockhaus M, Espevik T. Soluble TNF receptors in amniotic fluid and in urine from pregnant women. J Reprod Immunol 1992;22:105-16.
20. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci U S A 1992;89:4845-9.
21. Lantz M, Malik S, Slevin ML, Olsson I. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokines 1990;2:402-6.
22. van der Poll T, Jansen J, van Leenen D, von der Mohlen M, Levi M, ten Cate H, et al. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis 1993;168:955-60.
23. Austgulen R, Espevik T, Mecsei R, Scott H. Expression of receptors for tumor necrosis factor in human placenta at term. Acta Obstet Gynecol Scand 1992;71:417-24.
24. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? Obstet Gynecol 1994;84:937-40.
25. Opsjon S-L, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, et al. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993;169: 397-404.
26. 2 production in cultured bovine vascular endothelial cells. Arch Biochem Biophys 1992;292:600-4.
27. Ala Y, Palluy O, Favero J, Bonne C, Modat G, Dornard J. Hypoxia/reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production: Effects of free radical scavengers. Agents Actions 1992;37:134-9.
28. Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor-alpha/cachectin and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 1989;53: 488-98.